发布求助

文献互助智能选刊最新文献

Journal of Asthma and Allergy

查看最新文献

2443

中科院SCI期刊分区 WOS期刊分区历年影响因子历年发表同类期刊

期刊缩写：

J ASTHMA ALLERGY

影响因子：

3.7

ISSN：

print: 1178-6965

研究领域：

Medicine-Immunology and Allergy

自引率：

6.20%

Gold OA文章占比：

97.96%

原创研究文献占比：

80.14%

SCI收录类型：

Science Citation Index Expanded (SCIE) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)

期刊官网：

http://www.dovepress.com/journal-of-asthma-and-allergy-journal

期刊介绍英文：

An international, peer-reviewed journal publishing original research, reports, editorials and commentaries on the following topics: Asthma; Pulmonary physiology; Asthma related clinical health; Clinical immunology and the immunological basis of disease; Pharmacological interventions and new therapies. Although the main focus of the journal will be to publish research and clinical results in humans, preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies.

CiteScore：

CiteScore	SJR	SNIP	CiteScore排名
5.3	0.955	1.008	学科排名百分位大类：Medicine 小类：Pulmonary and Respiratory Medicine 51 / 155 67% 大类：Medicine 小类：Immunology and Allergy 118 / 233 49%

发文信息

中科院SCI期刊分区

大类	小类	TOP期刊	综述期刊
3区医学	3区过敏 ALLERGY 3区免疫学 IMMUNOLOGY 3区呼吸系统 RESPIRATORY SYSTEM	否	否

WOS期刊分区

学科分类
Q2ALLERGY Q2IMMUNOLOGY Q1RESPIRATORY SYSTEM

历年影响因子

2019年	3.7300
2020年	4.2580
2021年	3.0270
2022年	3.2000
2023年	3.7000

历年发表

2012年	11
2013年	16
2014年	14
2015年	14
2016年	26
2017年	36
2018年	30
2019年	37
2020年	77
2021年	151
2022年	185

投稿信息

出版语言：

English

出版国家(地区)：

NEW ZEALAND

审稿时长：

16 weeks

出版商：

Dove Medical Press

编辑部地址：

PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752

PubMed链接：

http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1178-6965%5BISSN%5D

Journal of Asthma and Allergy - 最新文献

Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus).

Pub Date : 2024-11-14 DOI: 10.2147/JAA.S488764 Juan Carlos Miralles-López, Francisco J Alvarez-Gutiérrez, Julio Delgado-Romero, Santiago Quirce, Jose Gregorio Soto-Campos, Ruben Andújar-Espinosa, Sheila Cabrejos-Perotti, Manuel Castilla-Martínez, Isabel Flores-Martín, Manuel José Pajarón-Fernández, José Valverde-Molina

Japanese Patients with Severe Asthma Identified as Responders to Omalizumab Treatment at 2 Years Based on the GETE Score Continued Treatment for an Extended Period.

Pub Date : 2024-11-14 DOI: 10.2147/JAA.S423256 Ai Goto, Sonoko Harada, Hitoshi Sasano, Yuuki Sandhu, Yuki Tanabe, Sumiko Abe, Shoko Ueda, Tomohito Takeshige, Kei Matsuno, Tetsutaro Nagaoka, Jun Ito, Ryo Atsuta, Kazuhisa Takahashi, Norihiro Harada

Differential Clinical Significance of FENO₂₀₀ and CANO in Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Asthma-COPD Overlap (ACO).

Pub Date : 2024-11-12 DOI: 10.2147/JAA.S486324 Guansheng Zeng, Jian Xu, Huadong Zeng, Cuilan Wang, Lichang Chen, Huapeng Yu

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。

Journal of Asthma and Allergy

Journal of Asthma and Allergy - 最新文献

Disease Modification in Asthma: Are We on the Right Way? A Multidisciplinary Expert Delphi Consensus (MODIASTHMA Consensus).

Japanese Patients with Severe Asthma Identified as Responders to Omalizumab Treatment at 2 Years Based on the GETE Score Continued Treatment for an Extended Period.

Differential Clinical Significance of FENO200 and CANO in Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Asthma-COPD Overlap (ACO).

Differential Clinical Significance of FENO₂₀₀ and CANO in Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Asthma-COPD Overlap (ACO).